Download PDF

Other users also viewed these articles

Second Mexican consensus on biologic therapy and small-molecule inhibitors in inflammatory bowel disease J.K. Yamamoto-Furusho; F.J. Bosques-Padilla; M.A. Martínez-Vázquez;
Rev Gastroenterol Mex. 2021;86:70-85
Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU J.K. Yamamoto-Furusho; D. Andrade; J. Barahona; S. Bautista; F. Bosques-Padilla; J. de Paula; M.T. Galiano; B. Iade; F. Juliao-Baños; G. Otoya; F. Steinwurz; E. Torres; G. Veitia; M. Barreiro-de Acosta;
Rev Gastroenterol Mex. 2022;87:89-102
Elevated fecal calprotectin: Does capsule endoscopy have a role in the diagnostic algorithm? S. Vibhishanan; P. Oka; S. Zammit; R. Sidhu;
10.1016/j.rgmxen.2024.06.006